NOVABAY PHARMACEUTICALS INC (NBY)
US66987P3001 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 3.13M | 5.36M | 7.50M | 11.95M | 6.94M | |||
| Receivables | 759.00K | 1.97M | 1.67M | 1.11M | 1.07M | |||
| Inventories | 2.88M | 3.44M | 3.22M | 610.00K | 490.00K | |||
| Other Current Assets | 388.00K | 560.00K | 770.00K | 570.00K | 890.00K | |||
| Total Current Assets | 7.15M | 11.33M | 13.17M | 14.24M | 9.38M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.38M | 1.95M | 600.00K | 520.00K | 1.36M | |||
| Goodwill | 0.00 | 350.00K | 4.53M | N/A | N/A | |||
| Intangibles | 0.00 | 2.28M | 5.20M | N/A | N/A | |||
| Other Non-Current Assets | 497.00K | 490.00K | 480.00K | 480.00K | 480.00K | |||
| Total Non-Current Assets | 1.88M | 5.07M | 10.81M | 1.00M | 1.84M | |||
| TOTAL ASSETS | 9.03M | 16.40M | 23.98M | 15.24M | 11.22M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 1.14M | 0.00 | 110.00K | 0.00 | 2.61M | |||
| Accrued Expenses | 1.06M | 1.37M | 1.00M | 1.80M | 2.71M | |||
| Accounts Payable | 1.13M | 1.08M | 1.05M | 300.00K | 330.00K | |||
| Other Current Liabilities | 946.00K | 1.81M | 1.29M | 730.00K | 40.00K | |||
| Total Current Liabilities | 4.28M | 4.26M | 3.44M | 2.83M | 5.69M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 1.44M | 1.59M | 10.37M | 90.00K | 4.56M | |||
| Total Non-Current Liabilities | 1.44M | 1.59M | 10.37M | 90.00K | 4.56M | |||
| TOTAL LIABILITIES | 5.72M | 5.85M | 13.81M | 2.92M | 10.25M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -174.85M | -158.15M | -141.89M | -136.06M | -125.02M | |||
| Additional Paid In Capital | 176.10M | 165.08M | 150.90M | 147.96M | 125.72M | |||
| Common Shares | 2.06M | 3.62M | 1.16M | 420.00K | 280.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 11.23M | 2.04M | 1.36M | 1.19M | 800.00K | |||
| Tangible Book Value per Share | 0.12 | 2.43 | -0.18 | 10.35 | 1.21 | |||
| Total Shareholders' Equity | 3.31M | 10.55M | 10.17M | 12.32M | 970.00K | |||
| TOTAL LIABILITIES AND EQUITY | 9.03M | 16.40M | 23.98M | 15.24M | 11.22M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 1.67 | 2.66 | 3.83 | 5.03 | 1.65 | |||
| Return On Assets (ROA) | -184.82% | -99.21% | -27.36% | -72.44% | -93.49% | |||
| Return On Equity (ROE) | -503.83% | -154.22% | -64.50% | -89.61% | -1081.44% | |||
All data in USD